Eric Trachtenberg
CIK 1646300 · SEE REMARKS · last filed 2024-01-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$915
Companies
3
Total Filings
28
Lifetime Open-Market Net
-$25.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KALA | SEE REMARKS | 1,386 | $0.66 | $915 | -$47.1K | 18 | 2024-01-05 |
| Aralez Pharmaceuticals Inc. (ARLZ) Delisted | GC, CCO & Secretary | 198,093 | — | — | $21.4K | 7 | 2018-03-21 |
| POZEN INC /NC (POZN) Delisted | Deputy General Counsel | 25,000 | — | — | $0 | 1 | 2015-06-25 |
Recent Filings · Page 3 of 3
28 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-21 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Sell (S) | −3,471 | -$5.9K | EDGAR |
| 2017-06-23 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Sell (S) | −7,720 | -$10.3K | EDGAR |
| 2017-05-12 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Grant (A) | +64,784 | $0 | EDGAR |
| 2016-05-18 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Buy (P) | +10,000 | $37.6K | EDGAR |
| 2016-03-18 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Grant (A) | +34,500 | $0 | EDGAR |
| 2016-02-17 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Grant (A) | +75,000 | $0 | EDGAR |
| 2016-02-09 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Other (J) | +25,000 | $0 | EDGAR |
| 2015-06-25 | POZEN INC /NC (POZN) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
Showing 21–28 of 28
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.